170 related articles for article (PubMed ID: 25338991)
1. Prognostic significance of the mucin component in stage III rectal carcinoma patients.
Wang M; Zhang YC; Yang XY; Wang ZQ
Asian Pac J Cancer Prev; 2014; 15(19):8101-5. PubMed ID: 25338991
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
[TBL] [Abstract][Full Text] [Related]
3. Mucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Marker of Response or Epiphenomenon?
Reynolds IS; O'Connell E; Fichtner M; Kay EW; McNamara DA; Prehn JHM; Burke JP
Am J Surg Pathol; 2020 Feb; 44(2):280-287. PubMed ID: 31567193
[TBL] [Abstract][Full Text] [Related]
4. Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis.
Halvorsen TB; Seim E
J Clin Pathol; 1988 Oct; 41(10):1068-72. PubMed ID: 2848059
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
[TBL] [Abstract][Full Text] [Related]
8. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
[TBL] [Abstract][Full Text] [Related]
9. Mucinous histology as a poor prognostic factor in young patients with Stage II rectal cancer: A population-based study.
Wu C; Bai J
J Cancer Res Ther; 2020; 16(7):1664-1671. PubMed ID: 33565514
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.
Zhao J; Xu J; Zhang R
Med Sci Monit; 2017 Oct; 23():4826-4833. PubMed ID: 28988257
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors.
Xu Y; Kimura N; Yoshida R; Lin H; Yoshinaga K
Oncol Rep; 2001; 8(5):1177-82. PubMed ID: 11496338
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors affecting recurrence and survival in patients with locally advanced rectal cancer.
Koca D; Binicier C; Oztop I; Yavuzsen T; Ellidokuz H; Yilmaz U
J BUON; 2012; 17(2):291-8. PubMed ID: 22740208
[TBL] [Abstract][Full Text] [Related]
13. Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
Wang L; Hirano Y; Heng G; Ishii T; Kondo H; Hara K; Obara N; Asari M; Kato T; Yamaguchi S
Anticancer Res; 2020 Mar; 40(3):1651-1659. PubMed ID: 32132070
[TBL] [Abstract][Full Text] [Related]
14. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases.
Gao P; Song YX; Xu YY; Sun Z; Sun JX; Xu HM; Wang ZN
Histopathology; 2013 Nov; 63(5):603-15. PubMed ID: 23991632
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.
Zhu L; Ling C; Xu T; Zhang J; Zhang Y; Liu Y; Fang C; Yang L; Zhuang W; Wang R; Ping J; Wang M
Pathol Oncol Res; 2021; 27():1609800. PubMed ID: 34276258
[TBL] [Abstract][Full Text] [Related]
16. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
[TBL] [Abstract][Full Text] [Related]
17. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.
Perez RO; Bresciani BH; Bresciani C; Proscurshim I; Kiss D; Gama-Rodrigues J; Pereira DD; Rawet V; Cecconnello I; Habr-Gama A
Int J Colorectal Dis; 2008 Aug; 23(8):757-65. PubMed ID: 18458918
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
Tarantino I; Hüttner FJ; Warschkow R; Schmied BM; Diener MK; Ulrich A
Ann Surg Oncol; 2016 May; 23(5):1576-86. PubMed ID: 26714956
[TBL] [Abstract][Full Text] [Related]
19. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
20. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis.
Wu CY; Yeh HZ; Shih RT; Chen GH
Cancer; 1998 Oct; 83(7):1312-8. PubMed ID: 9762931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
